New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs designed to target Alzheimer's.

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...

Carmen A. Guzman, 75, was reported missing on Sept. 19 when he was last seen with family at Hardee’s restaurant, 913 E. Main ...

We are at a turning point in the fight against Alzheimer’s disease with the emergence of disease-modifying therapies for ...

(RTTNews) - Eli Lilly and Company (LLY) Tuesday said its Kisunla for the treatment of adults with early symptomatic Alzheimer's disease has been approved by the Ministry of Health, Labour and Welfare ...

A diagnosis in the early stages may allow you to start treatments that can slow disease progression.

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s ...

Lilly said Japan is the second major market in which the drug has received approval, after the United States where it is sold ...

The Dutch company has created a device for the early detection of Alzheimer’s disease, and it is on its way to developing ...

Eli Lilly on Tuesday said Japan's Ministry of Health, Labour and Welfare Japan approved Kisunla for adults with early symptomatic Alzheimer's, including those with mild cognitive impairment as well as ...